IVF Hartmann Holding AG
SIX:VBSN

Watchlist Manager
IVF Hartmann Holding AG Logo
IVF Hartmann Holding AG
SIX:VBSN
Watchlist
Price: 150 CHF Market Closed
Market Cap: 357.2m CHF
Have any thoughts about
IVF Hartmann Holding AG?
Write Note

IVF Hartmann Holding AG
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

IVF Hartmann Holding AG
Total Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
IVF Hartmann Holding AG
SIX:VBSN
Total Equity
CHf141.2m
CAGR 3-Years
2%
CAGR 5-Years
3%
CAGR 10-Years
7%
Alcon AG
SIX:ALC
Total Equity
$20.6B
CAGR 3-Years
3%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
Coltene Holding AG
SIX:CLTN
Total Equity
CHf100m
CAGR 3-Years
1%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Medartis Holding AG
SIX:MED
Total Equity
CHf272.6m
CAGR 3-Years
7%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Ypsomed Holding AG
SIX:YPSN
Total Equity
CHf621.9m
CAGR 3-Years
17%
CAGR 5-Years
11%
CAGR 10-Years
10%
No Stocks Found

IVF Hartmann Holding AG
Glance View

Market Cap
360m CHF
Industry
Health Care

IVF HARTMANN Holding AG engages in the production and distribution of medical consumer products. The company is headquartered in Neuhausen Am Rheinfall, Schaffhausen and currently employs 340 full-time employees. The company went IPO on 2012-07-16. The firm's product range includes bandages, rheumatism plasters, baby products, feminine hygiene, cotton wool, first aid, diagnostics equipment, X-ray protection clothing, among others. The Company’s main clients usually are hospitals, doctors, surgery centers, care centers, pharmacies, drugstores, wholesalers and corporate medical centers. The firm also offers consulting services, on-site or in classrooms, related to the usage of its products. The firm's activities are divided into research and development, distribution logistics, production planning, purchase and four production segments: Coating; Medical Products; Elastic Bandages, and Hygiene Products. The company also operates subsidiaries located in Switzerland.

VBSN Intrinsic Value
142.96 CHF
Overvaluation 5%
Intrinsic Value
Price

See Also

What is IVF Hartmann Holding AG's Total Equity?
Total Equity
141.2m CHF

Based on the financial report for Jun 30, 2024, IVF Hartmann Holding AG's Total Equity amounts to 141.2m CHF.

What is IVF Hartmann Holding AG's Total Equity growth rate?
Total Equity CAGR 10Y
7%

Over the last year, the Total Equity growth was -1%. The average annual Total Equity growth rates for IVF Hartmann Holding AG have been 2% over the past three years , 3% over the past five years , and 7% over the past ten years .

Back to Top